NOTA Labs

NOTA Labs

Approved
San Francisco, United StatesFounded 2021notalabs.com

Nitric oxide (NO) is a powerful and critically important molecule that is produced throughout our bodies. It acts as an antiviral, antimicrobial, anti-thrombotic, anti inflammatory, and vasodilatory agent, in addition to being an important messaging molecule that regulates brain function. NOTA is focused on developing novel NO delivery systems and applications that augment our own body's NO production for treating and preventing a wide variety of life-threatening illnesses and conditions.

Founded
2021
Focus
Small Molecules

About

Nitric oxide (NO) is a powerful and critically important molecule that is produced throughout our bodies. It acts as an antiviral, antimicrobial, anti-thrombotic, anti inflammatory, and vasodilatory agent, in addition to being an important messaging molecule that regulates brain function. NOTA is focused on developing novel NO delivery systems and applications that augment our own body's NO production for treating and preventing a wide variety of life-threatening illnesses and conditions.

Funding History

1

Total raised: $3.2M

Seed$3.2MY CombinatorAug 15, 2022

Company Info

TypePrivate
Founded2021
LocationSan Francisco, United States
StageApproved
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile